Robert Burns
Stock Analyst at H.C. Wainwright
(4.85)
# 403
Out of 5,004 analysts
1071
Total ratings
48.3%
Success rate
22.1%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Reiterated: Buy | $20 | $11.38 | +75.75% | 1 | Sep 25, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 → $35 | $15.44 | +126.68% | 13 | Sep 25, 2026 | |
| BLSM BlossomHill Therapeutics | Reiterated: Buy | $35 | $20.47 | +70.98% | 2 | Sep 24, 2026 | |
| ACET Adicet Bio | Reiterated: Buy | $27 | $8.27 | +226.48% | 6 | Sep 21, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $55 | $31.43 | +74.99% | 29 | Sep 16, 2026 | |
| CRDF Cardiff Oncology | Upgraded: Buy | $9 | $1.28 | +603.13% | 14 | Sep 15, 2026 | |
| INBX Inhibrx Biosciences | Reiterated: Buy | $245 | $100.40 | +144.02% | 2 | Sep 9, 2026 | |
| PMVP PMV Pharmaceuticals | Reiterated: Buy | $5 | $1.34 | +274.53% | 23 | Sep 8, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $195 → $280 | $199.86 | +40.10% | 47 | Aug 27, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $51 → $55 | $26.81 | +105.15% | 46 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $1.88 | +1,123.40% | 16 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $29 | $17.73 | +63.56% | 36 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.10 | +376.19% | 8 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $68 | $24.63 | +176.09% | 23 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $47 | $30.10 | +56.15% | 18 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $25 | $11.70 | +113.68% | 16 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $27 | $13.18 | +104.86% | 49 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $5.73 | +266.49% | 34 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.89 | +482.01% | 42 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $3 | $1.73 | +73.41% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.99 | +100.50% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $21 | $2.93 | +616.72% | 8 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $23.65 | +43.76% | 31 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $65 | $45.17 | +43.90% | 12 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.33 | +200.43% | 23 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.30 | +202.33% | 7 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $57.95 | -3.36% | 25 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.25 | +780.00% | 30 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.29 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $1.57 | +917.88% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $19.63 | +78.30% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $19.78 | +112.34% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.50 | +420.00% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.59 | +94.99% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.80 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $3.99 | +626.82% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $99.26 | +30.97% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.86 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.67 | +558.68% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $12.60 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.91 | +318.85% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.54 | n/a | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $23.48 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.83 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $1.20 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.61 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $31.25 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.66 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.75 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $2.43 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.32 | n/a | 8 | Mar 5, 2021 |
Telix Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $20
Current: $11.38
Upside: +75.75%
Cullinan Therapeutics
Sep 25, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $15.44
Upside: +126.68%
BlossomHill Therapeutics
Sep 24, 2026
Reiterated: Buy
Price Target: $35
Current: $20.47
Upside: +70.98%
Adicet Bio
Sep 21, 2026
Reiterated: Buy
Price Target: $27
Current: $8.27
Upside: +226.48%
Cogent Biosciences
Sep 16, 2026
Reiterated: Buy
Price Target: $55
Current: $31.43
Upside: +74.99%
Cardiff Oncology
Sep 15, 2026
Upgraded: Buy
Price Target: $9
Current: $1.28
Upside: +603.13%
Inhibrx Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $245
Current: $100.40
Upside: +144.02%
PMV Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $5
Current: $1.34
Upside: +274.53%
Revolution Medicines
Aug 27, 2026
Reiterated: Buy
Price Target: $195 → $280
Current: $199.86
Upside: +40.10%
Zymeworks
Aug 26, 2026
Reiterated: Buy
Price Target: $51 → $55
Current: $26.81
Upside: +105.15%
Aug 21, 2026
Reiterated: Buy
Price Target: $23
Current: $1.88
Upside: +1,123.40%
Aug 21, 2026
Reiterated: Buy
Price Target: $28 → $29
Current: $17.73
Upside: +63.56%
Aug 20, 2026
Reiterated: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Aug 18, 2026
Reiterated: Buy
Price Target: $66 → $68
Current: $24.63
Upside: +176.09%
Aug 17, 2026
Reiterated: Buy
Price Target: $44 → $47
Current: $30.10
Upside: +56.15%
Aug 10, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $11.70
Upside: +113.68%
Aug 10, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $13.18
Upside: +104.86%
Aug 7, 2026
Reiterated: Buy
Price Target: $21
Current: $5.73
Upside: +266.49%
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $1.89
Upside: +482.01%
Jul 31, 2026
Downgraded: Hold
Price Target: $13 → $3
Current: $1.73
Upside: +73.41%
Jul 29, 2026
Reiterated: Buy
Price Target: $8
Current: $3.99
Upside: +100.50%
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $2.93
Upside: +616.72%
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $23.65
Upside: +43.76%
Jul 9, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $45.17
Upside: +43.90%
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.33
Upside: +200.43%
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $4.30
Upside: +202.33%
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $57.95
Upside: -3.36%
Jun 16, 2026
Reiterated: Buy
Price Target: $11
Current: $1.25
Upside: +780.00%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.29
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $1.57
Upside: +917.88%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $19.63
Upside: +78.30%
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $19.78
Upside: +112.34%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $2.50
Upside: +420.00%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.59
Upside: +94.99%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.80
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $3.99
Upside: +626.82%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $99.26
Upside: +30.97%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.86
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.67
Upside: +558.68%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $12.60
Upside: -
Feb 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.91
Upside: +318.85%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $8.54
Upside: n/a
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $23.48
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $6.83
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $1.20
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $5.61
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $31.25
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $4.66
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $2.75
Upside: n/a
Oct 22, 2021
Reiterated: Sell
Price Target: n/a
Current: $2.43
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.32
Upside: n/a